CytoMed Therapeutics
GDTC
$2.10
Share price
-2.33%
Change (1 day)
-37.31%
Change (1 year)
Categories
CytoMed Therapeutics (GDTC) - Cash on Hand
Cash on Hand as of December 2023 : $6.81 M
According to CytoMed Therapeutics's latest financial reports the company has $6.81 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
CytoMed Therapeutics - Cash on Hand chart (from 2021 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $1.18 M | -36.45% |
| 2021-12-31 | $1.85 M | 177.76% |
| 2020-12-31 | $0.66 M |